(Q44238473)

English

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 December 2017

Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients (English)

1 reference

Europe PubMed Central

1 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Catherine Jui-Ling Liu

1

1 reference

Europe PubMed Central

1 December 2017

Yu-Chieh Ko

2

1 reference

Europe PubMed Central

1 December 2017

Ching-Yu Cheng

3

1 reference

Europe PubMed Central

1 December 2017

Allen W Chiu

4

1 reference

Europe PubMed Central

1 December 2017

Joe C Chou

5

1 reference

Europe PubMed Central

1 December 2017

Wen-Ming Hsu

6

1 reference

Europe PubMed Central

1 December 2017

Jorn-Hon Liu

7

1 reference

Europe PubMed Central

1 December 2017

publication date

1 December 2002

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

109

1 reference

Europe PubMed Central

1 December 2017

12

1 reference

Europe PubMed Central

1 December 2017

2241-2247

1 reference

Europe PubMed Central

1 December 2017

Response of blood flow to warm and cold in normal and low-tension glaucoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of Ca2(+) -antagonist on visual field in low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of factors involved in the production of low tension glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic blood pressure in glaucoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory blood pressure monitoring in glaucoma. The nocturnal dip.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Unequal intraocular pressure and its relation to asymmetric visual field defects in low-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pressure-dependent neuroretinal rim loss in normal-pressure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive low-tension glaucoma: treatment to stop glaucomatous cupping and field loss when these progress despite normal intraocular pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Surgery for normal tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-blocker eyedrops and nocturnal arterial hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Around-the-clock intraocular pressure reduction with once-daily application of latanoprost by itself or in combination with timolol.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a filtering procedure in low tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular pressure reduction in normal-tension glaucoma patients. The Normal Tension Glaucoma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of the prostanoid receptors and of the contractile effects of prostaglandin F2ain human pial arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of latanoprost on regional blood flow and capillary permeability in the monkey eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of the effects of timolol and latanoprost on blood flow velocity of the retrobulbar vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of latanoprost and timolol-XE on hydrodynamics in the normal eye

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute effect of latanoprost on pulsatile ocular blood flow in normal eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2802%2901247-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(02)01247-2

1 reference

Europe PubMed Central

1 December 2017

1 reference

Europe PubMed Central

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44238473&oldid=2108842780"